Related references
Note: Only part of the references are listed.Adiponectin and Alcoholic Fatty Liver Disease
Christopher Q. Rogers et al.
IUBMB LIFE (2008)
Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism
Paul B. Yui et al.
NATURE CHEMICAL BIOLOGY (2008)
Statin reverses reduction of adiponectin receptor expression in infarcted heart and in TNF-α-treated cardiomyocytes in association with improved glucose uptake
Yukio Saito et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Preventive cardioprotection of erythropoietin against doxorubicin-induced cardiomyopathy
Xing Chen et al.
CARDIOVASCULAR DRUGS AND THERAPY (2007)
Future adverse cardiac events can be predicted by persistently low plasma adiponectin concentrations in men and marked reductions of adiponectin in women after acute myocardial infarction
Sunao Kojima et al.
ATHEROSCLEROSIS (2007)
Disruption of nitric oxide synthase 3 protects against the cardiac injury, dysfunction, and mortality induced by doxorubicin
Tomas G. Neilan et al.
CIRCULATION (2007)
Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress
Ling Tao et al.
CIRCULATION (2007)
Doxorubicin-induccd cardiomyopathy from the cardiotoxic mechanisms to management
Genzou Takemura et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2007)
Circulating adiponectin concentrations in patients with congestive heart failure
J. George et al.
HEART (2006)
Adiponectin plays an important role in efficient energy usage under energy shortage
Kiyomi Saito et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2006)
Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2 dependent mechanisms
R Shibata et al.
NATURE MEDICINE (2005)
Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure
C Kistorp et al.
CIRCULATION (2005)
Acute toxicity of doxorubicin on isolated perfused heart: response of kinases regulating energy supply
M Tokarska-Schlattner et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Adiponectin and adiponectin receptors
T Kadowaki et al.
ENDOCRINE REVIEWS (2005)
Nitric oxide inhibits myocardial apoptosis by preventing caspase-3 activity via S-nitrosylation
Y Maejima et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2005)
Plasma adiponectin levels and risk of myocardial infarction in men
T Pischon et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Cyclooxygenase-2 inhibitor treatment improves left ventricular function and mortality in a murine model of doxorubicin-induced heart failure
RM Delgado et al.
CIRCULATION (2004)
Adiponectin-mediated modulation of hypertrophic signals in the heart
R Shibata et al.
NATURE MEDICINE (2004)
Associations among plasma adiponectin, hypertension, left ventricular diastolic function and left ventricular mass index
SJ Hong et al.
BLOOD PRESSURE (2004)
The AMP-activated protein kinase cascade - a unifying system for energy control
D Carling
TRENDS IN BIOCHEMICAL SCIENCES (2004)
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects
T Yamauchi et al.
NATURE (2003)
Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin - Implications for metabolic regulation and bioactivity
UB Pajvani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
T Yamauchi et al.
NATURE MEDICINE (2002)
ATF3 inhibits doxorubicin-induced apoptosis in cardiac myocytes: A novel cardioprotective role of ATF3
K Nobori et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2002)
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30
N Maeda et al.
NATURE MEDICINE (2002)
The prognosis of heart failure in the general population - The Rotterdam Study
A Mosterd et al.
EUROPEAN HEART JOURNAL (2001)
Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients
K Hotta et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Adriamycin-induced heart failure: mechanisms and modulation
P Singal et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2000)
Cardiotoxicity of chemotherapeutic agents - Incidence, treatment and prevention
VB Pai et al.
DRUG SAFETY (2000)
Apoptotic cell death in heart failure
HN Sabbah
CARDIOVASCULAR RESEARCH (2000)
Share Paper
